Table 3

Tissues where validated imprinted genes most likely had biallelic expression
SNP(rs#) Chr Location Str Posterior Gene ID Gene Symbol Tissue Group
3807551 chr7 50627897 - 6.84E-17 2887 GRB10 Skeletal Muscle I
2585 chr11 2107019 + 9.09E-210 3481 IGF2 Liver I
10770125 chr11 2125589 + 7.15E-43 3481 IGF2 Liver I
8813 chr11 3065081 - 1.20E-11 114879 OSBPL5 Colon I
17178177 chr11 3065446 + 6.83E-10 114879 OSBPL5 Colon I
10770125 chr11 2125589 + 7.15E-43 51214 IGF2AS Liver I
7121 chr20 56912201 + 0 2778 GNAS Lymph node I
854547 chr7 94761791 + 1.61E-10 55607 PPP1R9A Cerebellum II
8164 chr11 6372457 + 1.54E-30 6609 SMPD1 Cerebellum II
7951904 chr11 6369506 + 2.68E-10 6609 SMPD1 Cerebellum II
11601088 chr11 6371967 + 1.62E-09 6609 SMPD1 Cerebellum II
2272666 chr8 1.46E+08 + 2.63E-17 79581 GPR172A Cerebellum II
2280840 chr8 1.46E+08 + 1.05E-57 79581 GPR172A Cerebellum II
2615374 chr8 1.41E+08 + 1.51E-13 51305 KCNK9 Cerebellum II

Posteriors were calculated based on Group I or II (see Table 5). The “Tissue” column indicates where genes were most likely biallelically expressed. Genes with contradictory evidence (i.e., genes had posteriors <10-8 and posteriors ≥0.2) were discarded. IGF2, OSBPL5, SMPD1 and GPR172A had at least 2 SNPs with posteriors less than 10-8. Abbreviations are the same as in Table 2.

Li et al.

Li et al. BMC Bioinformatics 2012 13:271   doi:10.1186/1471-2105-13-271

Open Data